《美國股市》道指高收387點 納指全周揚2.6%跑出
美國國債孳息率由近期高位回落,美股周五高收。道指結束連跌四周,收市升387.4點或1.17%,收報33,390.97點。全周升1.75%。
標普500指數高收64.29點或1.61%,報4,045.64點。全周升1.9%。
納指收市升226.02點或1.97%,報11,689.01點。全周升2.58%。
Meta(META.US)VR裝置Quest Pro本周起減價500美元至999.99美元, Quest 2減70美元至429.99美元,股價收市飆6.14%;蘋果(AAPL.US)獲大摩吹奏,股價12個月內或漲20%,該股終升3.51%;Tesla(TSLA.US)升3.61%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.